A detailed history of Mid Atlantic Capital Management, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Mid Atlantic Capital Management, Inc. holds 2,250 shares of VTRS stock, worth $29,812. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,250
Holding current value
$29,812
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$10.32 - $12.13 $23,220 - $27,292
2,250 New
2,250 $26.1 Million
Q1 2024

Nov 12, 2024

SELL
$11.27 - $13.53 $2,287 - $2,746
-203 Reduced 7.27%
2,588 $30.9 Million
Q4 2023

Nov 12, 2024

BUY
$8.77 - $10.85 $4,744 - $5,869
541 Added 24.04%
2,791 $30.2 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $16.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Mid Atlantic Capital Management, Inc. Portfolio

Follow Mid Atlantic Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid Atlantic Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid Atlantic Capital Management, Inc. with notifications on news.